Yonsa and Savella drug interactions - a phase IV clinical study of FDA data
Summary:
We study 7,799 people who take Yonsa (abiraterone acetate) and Savella (milnacipran hydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Yonsa and Savella. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Yonsa?
Yonsa has active ingredients of abiraterone acetate. eHealthMe is studying from 270 Yonsa users. Check the latest studies of Yonsa.
What is Savella?
Savella has active ingredients of milnacipran hydrochloride. It is often used in fibromyalgia. eHealthMe is studying from 7,529 Savella users. Check the latest studies of Savella.
No report is found.
Do you take Yonsa and Savella?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on abiraterone acetate and milnacipran hydrochloride (the active ingredients of Yonsa and Savella, respectively), and Yonsa and Savella (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Metolazone cause Vomiting Aggravated? - 3 seconds ago
- Claritin and Astelin drug interactions for women aged 40-49 - 3 seconds ago
- Could Neurontin cause Haemangioma? - 3 seconds ago
- Drug interactions of Cyanocobalamin and Zaroxolyn - 3 seconds ago
- Fish Oil and Mobic drug interactions for women aged 60+ - 7 seconds ago
- Vfend and Hair Thinning for Men aged 40-49 - 15 seconds ago
- Vfend and Loss Of Hair for Men aged 40-49 - 15 seconds ago
- Vfend and Hairloss for Men aged 40-49 - 15 seconds ago
- Vfend and Baldness for Men aged 40-49 - 15 seconds ago
- Vfend and Alopecia for Men aged 40-49 - 16 seconds ago